...
首页> 外文期刊>Neurochemistry International: The International Journal for the Rapid Publication of Critical Reviews, Preliminary and Original Research Communications in Neurochemistry >Phenotype dependent differential effects of interleukin-1beta and amyloid-beta on viability and cholinergic phenotype of T17 neuroblastoma cells.
【24h】

Phenotype dependent differential effects of interleukin-1beta and amyloid-beta on viability and cholinergic phenotype of T17 neuroblastoma cells.

机译:白细胞介素1β和淀粉样β的表型依赖性差异作用对T17神经母细胞瘤细胞生存力和胆碱能表型的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Amyloid-beta accumulation in brains of Alzheimer's disease (AD) victims is accompanied by glial inflammatory reactions and preferential loss of cholinergic neurons. Therefore, the aim of this study was to find out whether proinflamatory cytokine interleukin 1beta (IL1beta) modifies effects of amyloid-beta (Abeta) on viability and cholinergic phenotype of septum derived T17 cholinergic neuroblastoma cells. In nondifferentiated T17 cells (NC) Abeta(25-35) (1 microg/ml) caused no changes in choline acetyltransferase (ChAT) activity, acetylcholine (ACh) release, subcellular distribution of acetyl-CoA, but doubled content of trypan blue positive cells. IL1beta (10 ng/ml) increased ACh release (125%) but did not change other parameters of NC. In the presence of Abeta IL1beta also increased ChAT activity (47%), ACh release (100%) but had no effect on acetyl-CoA distribution and cell viability. Differentiation with retinoic acid and dibutyryl cyclic AMP caused over two-fold increase of ChAT activity and ACh content, four-fold increase of ACh release and about 50% decrease of acetyl-CoA level in the mitochondria. In differentiated cells (DC), Abeta decreased ChAT activity (31%), ACh release (47%) and content of acetyl-CoA (80%) in cell cytoplasmic compartment, whereas IL1beta elevated ChAT activity (54%) and ACh release (32%). IL1beta totally reversed Abeta-evoked inhibition of ChAT activity and ACh release and restored control level of cytoplasmic acetyl-CoA but increased fraction of nonviable cells to 25%. Thus, IL1beta could compensate Abeta-evoked cholinergic deficits through the restoration of adequate expression of ChAT and provision of acetyl-CoA to cytoplasmic compartment in cholinergic neurons that survive under such pathologic conditions. These data indicate that IL1beta possess independent cholinotrophic and cholinotoxic activities that may modify Abeta effects on cholinergic neurons.
机译:阿尔茨海默氏病(AD)受害者大脑中的淀粉样β积累伴随着神经胶质炎性反应和胆碱能神经元的优先丢失。因此,本研究的目的是发现促炎性细胞因子白介素1β(IL1beta)是否能改变淀粉样β(Abeta)对源自隔膜的T17胆碱能神经母细胞瘤细胞的生存能力和胆碱能表型的影响。在未分化的T17细胞(NC)中,Abeta(25-35)(1 microg / ml)不会引起胆碱乙酰转移酶(ChAT)活性,乙酰胆碱(ACh)释放,乙酰辅酶A的亚细胞分布变化,但锥虫蓝阳性的含量增加了一倍细胞。 IL1beta(10 ng / ml)增加了ACh的释放(125%),但没有改变NC的其他参数。在存在Abeta的情况下,IL1beta还可增加ChAT活性(47%),ACh释放(100%),但对乙酰辅酶A分布和细胞活力没有影响。与维甲酸和二丁酰环AMP的分化导致线粒体中ChAT活性和ACh含量增加两倍以上,ACh释放量增加四倍,乙酰辅酶A水平降低约50%。在分化细胞(DC)中,Abeta降低了细胞质区室的ChAT活性(31%),ACh释放(47%)和乙酰辅酶A的含量(80%),而IL1beta升高了ChAT活性(54%)和ACh释放( 32%)。 IL1beta完全逆转了Abeta引起的ChAT活性和ACh释放的抑制作用,并恢复了细胞质乙酰辅酶A的控制水平,但使无效细胞的比例提高到25%。因此,IL1beta可以通过恢复ChAT的充分表达并向在这种病理条件下存活的胆碱能神经元的细胞质区室提供乙酰辅酶A来补偿Abeta诱发的胆碱能缺陷。这些数据表明,IL1beta具有独立的胆碱营养和胆毒性作用,可能会改变Abeta对胆碱能神经元的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号